Academic literature on the topic 'Bowman-Birk inhibitor'
Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles
Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Bowman-Birk inhibitor.'
Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.
You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.
Journal articles on the topic "Bowman-Birk inhibitor"
1
Wu, Y. Victor, and David J. Sessa. "Conformation of Bowman-Birk Inhibitor." Journal of Agricultural and Food Chemistry 42, no. 10 (October 1994): 2136–38. http://dx.doi.org/10.1021/jf00046a012.
Full text
2
Chen, Xi, Dong Chen, Linyuan Huang, Xiaoling Chen, Mei Zhou, Xinping Xi, Chengbang Ma, Tianbao Chen, and Lei Wang. "Identification and Target-Modification of SL-BBI: A Novel Bowman–Birk Type Trypsin Inhibitor from Sylvirana latouchii." Biomolecules 10, no. 9 (August 28, 2020): 1254. http://dx.doi.org/10.3390/biom10091254.
Full textAbstract:
The peptides from the ranacyclin family share similar active disulphide loop with plant-derived Bowman–Birk type inhibitors, some of which have the dual activities of trypsin inhibition and antimicrobial. Herein, a novel Bowman–Birk type trypsin inhibitor of the ranacyclin family was identified from the skin secretion of broad-folded frog (Sylvirana latouchii) by molecular cloning method and named as SL-BBI. After chemical synthesis, it was proved to be a potent inhibitor of trypsin with a Ki value of 230.5 nM and showed weak antimicrobial activity against tested microorganisms. Modified analogue K-SL maintains the original inhibitory activity with a Ki value of 77.27 nM while enhancing the antimicrobial activity. After the substitution of active P1 site to phenylalanine and P2′ site to isoleucine, F-SL regenerated its inhibitory activity on chymotrypsin with a Ki value of 309.3 nM and exhibited antiproliferative effects on PC-3, MCF-7 and a series of non-small cell lung cancer cell lines without cell membrane damage. The affinity of F-SL for the β subunits in the yeast 20S proteasome showed by molecular docking simulations enriched the understanding of the possible action mode of Bowman–Birk type inhibitors. Further mechanistic studies have shown that F-SL can activate caspase 3/7 in H157 cells and induce apoptosis, which means it has the potential to become an anticancer agent.
3
Wan, X. Steven, David G. Serota, Jeffrey H. Ware, James A. Crowell, and Ann R. Kennedy. "Detection of Bowman-Birk Inhibitor and Anti-Bowman-Birk Inhibitor Antibodies in Sera of Humans and Animals Treated With Bowman-Birk Inhibitor Concentrate." Nutrition and Cancer 43, no. 2 (July 2002): 167–73. http://dx.doi.org/10.1207/s15327914nc432_7.
Full text
4
Othman, Tajul Ariffien, Norliza Abu Bakar, Rabiatul Adawiah Zainal Abidin, Maziah Mahmood, Noor Baity Saidi, and Noor Azmi Shaharuddin. "Potential of Plant’s Bowman-Birk Protease Inhibitor in Combating Abiotic Stresses: A Mini Review." Bioremediation Science and Technology Research 2, no. 2 (January 31, 2015): 25–33. http://dx.doi.org/10.54987/bstr.v2i2.179.
Full textAbstract:
Bowman-Birk Inhibitor (BBI) is one of the subfamilies of serine protease inhibitors. Numerousstudies have shown that in plants, BBI functions as part of their defense mechanism againstpathogens and microorganisms. The BBI is also known to have anti-carcinogenic properties.Furthermore, the BBI has been reported to function in controlling abiotic stresses such assalinity and drought stresses.. Abiotic stresses are the major problems in agricultural industry.Therefore, numerous researches have been carried out to characterize the BBI and to determineits roles during biotic and abiotic stresses. This paper presents a review regarding therelationship between Bowman-Birk inhibitor and the plant defensive mechanism against abioticstresses.
5
Pusztai, A., G. Grant, S. Bardocz, K. Baintner, E. Gelencser, and S. W. Ewen. "Both free and complexed trypsin inhibitors stimulate pancreatic secretion and change duodenal enzyme levels." American Journal of Physiology-Gastrointestinal and Liver Physiology 272, no. 2 (February 1, 1997): G340—G350. http://dx.doi.org/10.1152/ajpgi.1997.272.2.g340.
Full textAbstract:
Secretion of pancreatic digestive enzymes was measured in pancreatic cannulated rats after duodenal stimulation with Kunitz or Bowman-Birk protease inhibitors or their complexes with trypsin and/or chymotrypsin. Free and complexed inhibitors were bound by the duodenal epithelium, stimulated the discharge of cholecystokinin, and significantly increased secretion rates of alpha-amylase, trypsinogen, and chymotrypsinogen. Inasmuch as secretion rates returned to basal levels with cholecystokinin-A receptor antagonists, the stimulation was likely to be mediated by cholecystokinin. Soya factors also influenced the duodenal concentration of pancreatic enzymes under simulated feeding conditions. Thus the level of alpha-amylase increased while the trypsin concentration decreased in rats gavaged with free or complexed inhibitors. The same was true for chymotrypsin when the Bowman-Birk inhibitor was used, but the Kunitz inhibitor and its trypsin complex actually raised the luminal concentration of chymotrypsin. Accordingly, because soya inhibitors remained effective in stimulating pancreatic secretion after elimination of their inhibitory activity by complex formation, it is questionable whether the signal for cholecystokinin secretion was solely due to lowering of duodenal protease levels.
6
&NA;. "Bowman-Birk inhibitor concentrate for chemoprevention?" Inpharma Weekly &NA;, no. 1272 (January 2001): 11. http://dx.doi.org/10.2165/00128413-200112720-00024.
Full text
7
Song, Hyun Kyu, and Se Won Suh. "Preliminary X-ray crystallographic analysis of Bowman–Birk trypsin inhibitor from barley seeds." Acta Crystallographica Section D Biological Crystallography 54, no. 3 (May 1, 1998): 441–43. http://dx.doi.org/10.1107/s0907444997010986.
Full textAbstract:
Bowman–Birk trypsin inhibitor from barley seeds has been crystallized at room temperature using polyethylene glycol as precipitant. The crystal is tetragonal, belonging to the space group P41212 (or P43212), with unit cell parameters of a = b = 62.48 and c = 94.63 Å. The asymmetric unit contains one molecule of Bowman–Birk trypsin inhibitor with corresponding crystal volume per protein mass (Vm ) of 2.89 Å3 Da−1 and the solvent content of 57% by volume. The crystals diffract to at least 1.9 Å Bragg spacing upon exposure to synchrotron X-rays. X-ray data to 1.9 Å have been collected from a native crystal.
8
Miao, Yuxi, Guanzhu Chen, Xinping Xi, Chengbang Ma, Lei Wang, James F. Burrows, Jinao Duan, Mei Zhou, and Tianbao Chen. "Discovery and Rational Design of a Novel Bowman-Birk Related Protease Inhibitor." Biomolecules 9, no. 7 (July 14, 2019): 280. http://dx.doi.org/10.3390/biom9070280.
Full textAbstract:
Anuran amphibian skin secretions are a rich source of peptides, many of which represent novel protease inhibitors and can potentially act as a source for protease inhibitor drug discovery. In this study, a novel bioactive Bowman-Birk type inhibitory hexadecapeptide of the Ranacyclin family from the defensive skin secretion of the Fukien gold-striped pond frog, Pelophlax plancyi fukienesis, was successfully isolated and identified, named PPF-BBI. The primary structure of the biosynthetic precursor was deduced from a cDNA sequence cloned from a skin-derived cDNA library, which contains a consensus motif representative of the Bowman-Birk type inhibitor. The peptide was chemically synthesized and displayed a potent inhibitory activity against trypsin (Ki of 0.17 µM), as well as an inhibitory activity against tryptase (Ki of 30.73 µM). A number of analogues of this peptide were produced by rational design. An analogue, which substituted the lysine (K) at the predicted P1 position with phenylalanine (F), exhibited a potent chymotrypsin inhibitory activity (Ki of 0.851 µM). Alternatively, a more potent protease inhibitory activity, as well as antimicrobial activity, was observed when P16 was replaced by lysine, forming K16-PPF-BBI. The addition of the cell-penetrating peptide Tat with a trypsin inhibitory loop resulted in a peptide with a selective inhibitory activity toward trypsin, as well as a strong antifungal activity. This peptide also inhibited the growth of two lung cancer cells, H460 and H157, demonstrating that the targeted modifications of this peptide could effectively and efficiently alter its bioactivity.
9
de Freitas, Sonia Maria, Luciano Paulino Silva, Jose Roberto S. A. Leite, and Carlos Bloch Jr. "Stability of a black eyed pea trypsin/chymotrypsin inhibitor (BTCI)." Protein & Peptide Letters 7, no. 6 (December 2000): 397–401. http://dx.doi.org/10.2174/092986650706221207164315.
Full textAbstract:
Abstract: The stability of BTCI has been investigated as function of pH and temperature, following its inhibitory activity against trypsin. The isolated inhibitor of 9,084 Oa is stable over pH 3 to 12 at 25°C. BTCI showed high thermal stability ranging from 25 to 95°C at pH 3 and 7. However, the protein lost about 20% of its inhibitory activity over 75°C at pH 8.2. The results indicated that BTCI is extremely stable to heat and pH as typical of Bowman-Birk inhibitors.
10
Ahmed, E. M., and J. A. Applewhite. "Characterization of Trypsin Inhibitor in Florunner Peanut Seeds (Arachis hypogaea L.)1." Peanut Science 15, no. 2 (July 1, 1988): 81–84. http://dx.doi.org/10.3146/i0095-3679-15-2-10.
Full textAbstract:
Abstract Florunner peanut seeds contained five trypsin isoinhibitors. Amino acid profiles of the trypsin inhibitors fraction showed high levels of aspartic acid, half-cystine and serine and low levels of histidine and tyrosine. The molecular weight of the inhibitor was 8.3 KDa. The presence of multiforms of this inhibitor, its low molecular weight and the high amount of half-cystine indicate that peanut trypsin inhibitor is of the Bowman-Birk type.
Dissertations / Theses on the topic "Bowman-Birk inhibitor"
1
Martins, Thiago Fernandes. "Purificação e caracterização bioquímica de um inibidor tipo Bowman-Birk de sementes Luetzelburgia auriculata (Allemão) Ducke." reponame:Repositório Institucional da UFC, 2015. http://www.repositorio.ufc.br/handle/riufc/16473.
Full textAbstract:
MARTINS, Thiago Fernandes. Purificação e caracterização bioquímica de um inibidor tipo Bowman-Birk de sementes Luetzelburgia auriculata (Allemão) Ducke. 2015. 102 f. Dissertação (mestrado em bioquímica)- Universidade Federal do Ceará, Fortaleza-CE, 2015.<br>Submitted by Elineudson Ribeiro (elineudsonr@gmail.com) on 2016-03-18T20:49:01Z
No. of bitstreams: 1
2016_dis_tfmartins.pdf: 2013799 bytes, checksum: b9c6f661705801d01e9be5b261d014c0 (MD5)<br>Approved for entry into archive by José Jairo Viana de Sousa (jairo@ufc.br) on 2016-04-28T20:46:41Z (GMT) No. of bitstreams: 1
2016_dis_tfmartins.pdf: 2013799 bytes, checksum: b9c6f661705801d01e9be5b261d014c0 (MD5)<br>Made available in DSpace on 2016-04-28T20:46:41Z (GMT). No. of bitstreams: 1
2016_dis_tfmartins.pdf: 2013799 bytes, checksum: b9c6f661705801d01e9be5b261d014c0 (MD5)
Previous issue date: 2015<br>Plant protease inhibitors are proteins of low molecular weight, usually present in high concentrations in storage tissues, particularly in seeds of species belong to the Fabaceae family. In this study, a Bowman-Birk protease inhibitor (LzaBBI) was purified from the saline extract of the Luetzelburgia auriculata seeds After boiling of this saline extract, the inhibitor was purified by affinity chromatography on Sepharose® 4B-anhydrotrypsin, followed by ion exchange chromatography on DEAE Sepharose and reverse phase chromatography. Under reducing conditions or not, LzaBBI showed an apparent molecular mass of 17.3 kDa and a single polypeptide chain. The NH2-terminal sequencing of the LzaBBI showed high similarity with other Bowman-Birk inhibitors of legumes. LzaBBI remained stable after boiling at 98 °C for 120 min and also remained stable with trypsin inhibitory activity after incubation in pH buffers with pHs varying from 2 to 11. In addition to its relevant structural stability, of importance in future biotechnological applications, LzaBBI showed negative impact on the Staphylococcus aureus development when at low doses.<br>Inibidores de proteases vegetais são proteínas de baixa massa molecular, geralmente presentes em altas concentrações nos tecidos de armazenamento, particularmente em sementes de plantas pertencentes à família Fabaceae. Neste estudo, um inibidor de proteases pertencente à família Bowman-Birk (LzaBBI) foi purificado a partir do extrato salino de sementes de Luetzelburgia auriculata. Após fervura desse extrato salino, o inibidor foi purificado por cromatografia de afinidade em matriz de anidrotripsina-Sepharose® 4B, seguido de cromatografia em matriz de troca iônica (DEAE Sepharose) e cromatografia em fase reversa. Em condições redutoras, ou não, o LzaBBI apresentou massa molecular aparente de 17,3 kDa, e uma única cadeia polipeptídica. Sua sequência NH2-terminal possui alta similaridade com inibidores do tipo Bowman-Birk de leguminosas. O LzaBBI permaneceu estável após fervura a 98 °C por 120 min, bem como após incubado na faixa de pHs entre 2 a 11. Além de possuir relevante estabilidade estrutural, de importância para futuras aplicações biotecnológicas, apresentou efeito negativo no crescimento da bactéria Staphylococcus aureus, quando em baixas concentrações.
2
Martins, Thiago Fernandes. "PurificaÃÃo e caracterizaÃÃo bioquÃmica de um inibidor tipo Bowman-Birk de sementes Luetzelburgia auriculata (AllemÃo) Ducke." Universidade Federal do CearÃ, 2015. http://www.teses.ufc.br/tde_busca/arquivo.php?codArquivo=15486.
Full textAbstract:
CoordenaÃÃo de AperfeiÃoamento de Pessoal de NÃvel Superior<br>Inibidores de proteases vegetais sÃo proteÃnas de baixa massa molecular, geralmente presentes em altas concentraÃÃes nos tecidos de armazenamento, particularmente em sementes de plantas pertencentes à famÃlia Fabaceae. Neste estudo, um inibidor de proteases pertencente à famÃlia Bowman-Birk (LzaBBI) foi purificado a partir do extrato salino de sementes de Luetzelburgia auriculata. ApÃs fervura desse extrato salino, o inibidor foi purificado por cromatografia de afinidade em matriz de anidrotripsina-Sepharose 4B, seguido de cromatografia em matriz de troca iÃnica (DEAE Sepharose) e cromatografia em fase reversa. Em condiÃÃes redutoras, ou nÃo, o LzaBBI apresentou massa molecular aparente de 17,3 kDa, e uma Ãnica cadeia polipeptÃdica. Sua sequÃncia NH2-terminal possui alta similaridade com inibidores do tipo Bowman-Birk de leguminosas. O LzaBBI permaneceu estÃvel apÃs fervura a 98 ÂC por 120 min, bem como apÃs incubado na faixa de pHs entre 2 a 11. AlÃm de possuir relevante estabilidade estrutural, de importÃncia para futuras aplicaÃÃes biotecnolÃgicas, apresentou efeito negativo no crescimento da bactÃria Staphylococcus aureus, quando em baixas concentraÃÃes.<br>Plant protease inhibitors are proteins of low molecular weight, usually present in high concentrations in storage tissues, particularly in seeds of species belong to the Fabaceae family. In this study, a Bowman-Birk protease inhibitor (LzaBBI) was purified from the saline extract of the Luetzelburgia auriculata seeds After boiling of this saline extract, the inhibitor was purified by affinity chromatography on Sepharose 4B-anhydrotrypsin, followed by ion exchange chromatography on DEAE Sepharose and reverse phase chromatography. Under reducing conditions or not, LzaBBI showed an apparent molecular mass of 17.3 kDa and a single polypeptide chain. The NH2-terminal sequencing of the LzaBBI showed high similarity with other Bowman-Birk inhibitors of legumes. LzaBBI remained stable after boiling at 98 ÂC for 120 min and also remained stable with trypsin inhibitory activity after incubation in pH buffers with pHs varying from 2 to 11. In addition to its relevant structural stability, of importance in future biotechnological applications, LzaBBI showed negative impact on the Staphylococcus aureus development when at low doses.
3
José, Márcia Ometto de Mello Alves. "Inibidores de proteinase do tipo Bowman-Birk: evolução molecular, expressão na superfície de fagos filamentosos e seu papel na interação planta-inseto." Universidade de São Paulo, 2002. http://www.teses.usp.br/teses/disponiveis/11/11137/tde-14022003-152133/.
Full textAbstract:
Os inibidores inibidores de serino proteinases do tipo Bowman-Birk (BBI) possuem dois sítios ativos e são encontrados em plantas das famílias Fabaceae e Poaceae. Neste trabalho foi apresentada a estrutura primária e o padrão de expressão de 14 seqüências expressas (EST, expressed sequence tags) de BBI putativos encontradas no banco de dados do "Projeto Transcriptoma da Cana-de-açúcar" (SUCEST). Estas quatorze seqüências foram utilizadas em conjunto com outras 87 seqüências de BBI previamente descritas e depositadas no banco de dados "GenBank" para a construção de árvores filogenéticas da família BBI. A análise filogenética mostrou que os BBI de monocotiledôneas e dicotiledôneas podem ser claramente separados em diferentes grupos e a topologia das árvores filogenéticas sugere um padrão evolutivo diferente das famílias de BBI em plantas. Os inibidores de dicotiledôneas são bem conservados e acumularam diferenças sutis durante a evolução. Em contrapartida, os inibidores de monocotiledôneas são altamente variáveis, indicando a ocorrência de um processo evolutivo interessante, baseado em eventos de duplicação intragênica e mutação. Dois inibidores de serino proteinases, um de tripsina e outro de quimotripsina, derivados do gene que codifica o inibidor Bowman-Birk de soja, foram expressos na superfície do fago filamentoso M13 e utilizados para a construção de bibliotecas de variantes. Para tal foram feitas mutações em quatro aminoácidos do sítio ativo destes inibidores e duas bibliotecas de expressão na superfície de fagos filamentosos foram construídas. Posteriormente, estas bibliotecas foram utilizadas para a seleção de variantes que melhor interagiam com a tripsina bovina e de Diatraea saccharalis e com as enzimas digestivas presentes no extrato intestinal desta praga. Os variantes selecionados foram seqüenciados, analisados e caracterizados. Os resultados mostraram que a técnica de expressão na superfície de fagos filamentosos foi eficiente para selecionar novos inibidores. Além disto, com as mutações realizadas, foi possível transformar a alça de inibição de quimotripsina em uma alça de inibição de tripsina.<br>The Bowman-Birk inhibitors (BBIs) are double headed inhibitors of serine proteinase found in plants from Fabaceae and Poaceae families. We describe the primary structure and the gene expression profile of 14 putative BBIs from the sugarcane expressed sequence tag (SUCEST) database and show how we used these newly discovered sequences together with 87 previously described BBI sequences from the "GenBank" database to construct phylogenetic trees for the BBI family. Phylogenetic analysis revealed that BBI-type inhibitors from monocotyledonous and dicotyledonous plants could be clearly separated into different groups, while the overall topology of the BBI tree suggests a different pattern of evolution for BBI families in flowering plants. We also found that BBI proteinase inhibitors from dicotyledonous plants were well conserved, accumulating only slight differences during their evolution. In addition, we found that BBIs from monocotyledonous plants were highly variable, indicating an interesting process of evolution based on internal gene duplications and mutation events. Two serine-type proteinase inhibitors, a trypsin and a chymotrypsin, both derived from the soybean Bowman-Birk inhibitor, were expressed on the surface of a filamentous phage. Site mutations were made in four positions of the reactive sites of these inhibitors and two phage-display libraries were constructed. Later, these libraries were used to select better ligands to the bovine and Diatraea saccharalis trypsin and to the midgut enzymes of this insect pest. The selected variants were sequenced, analyzed and characterized. The results showed that the phage-display technique is efficient to select new proteinase inhibitors. Furthermore, it was possible to modify the chymotrypsin loop into a trypsin loop using the library constructed by the insertion of a degenerated primer.
4
Kruger, Sarah Jane, and n/a. "Characterisation of Proteins from Grevillea robusta and NMR Studies of the Serine Protease Inhibitor." Griffith University. School of Science, 2004. http://www4.gu.edu.au:8080/adt-root/public/adt-QGU20040618.150708.
Full textAbstract:
Proteins that recognise the sugar surface structures on cells have an enormous potential to be used as tools in the characterisation of these structures. A group of proteins, called lectins, have been identified that can bind to carbohydrate complexes on the receptors of cells. The crude extract from Grevillea robusta seeds was found to contain lectin-like proteins that were different from most other lectins, as they would specifically target the receptors of white blood cells and not those found on red blood cells. Therefore, the lectin isolated from G.robusta could be used as a tool to identify the specific surface structures on white blood cells. The lectin was isolated using affinity chromatography where a complex (oligosaccharide) matrix was used. Agglutination, binding and sugar inhibition assays confirmed the isolated protein was a lectin. The lectin was found in low amounts (up to 5% of the total protein content) within the seeds of G.robusta. As a result of this low yield, the identification of the lectin by PAGE was difficult because the levels of protein were beyond the detection limit of the commercial staining reagents. The lectin was called the GR2 protein and was characterised as a monocot mannose binding lectin based on its sugar specificity for only mannose. A serine protease inhibitor was isolated from the seeds of G.robusta using two different chromatography methods, reverse phase HPLC (GR1.HPLC) and gel filtration chromatography (GR1.GF). Ion exchange chromatography was used to initially separate the proteins in the crude extract and the fraction containing the GR1 protein was further purified using reverse phase HPLC (GR1.HPLC). N-terminal sequencing results of the GR1.HPLC protein, showed evidence of proteolytic cleavage during the extraction process, which lead to the second purification method being established. Protease inhibitors were added to the buffers prior to being purified by gel filtration chromatography, which resulted in the GR1 protein being isolated from the crude extract without the presence of the contaminating protein. Mass spectroscopy identified the molecular weight of the GR1 protein to be 6669Da and the full amino acid sequence was derived by cDNA techniques. Sequence alignment studies of the GR1 protein showed significant similarities with the Bowman-Birk inhibitor. The positioning of the cysteine residues were conserved throughout the Bowman-Birk superfamily, however these residues were not conserved within the GR1 protein. Competitive inhibition assays on the GR1 protein revealed the protein could inhibit both trypsin and chymotrypsin at similar levels to that seen for the Bowman-Birk inhibitor. Therefore, the GR1 protein was characterised as a member of the Bowman-Birk superfamily of serine protease inhibitors. The three-dimensional structure of the GR1 protein was determined using two-dimensional NMR spectroscopy. Computer programs such as XEASY, DYANA and SYBYL® were used to tabulate the information taken from the 2D experiments, generate structures and minimise these structures respectively. The solution structure of the GR1 protein was found to contain a region of antiparallel β-sheet structure that corresponded to the trypsin binding site and the remainder of the protein consisted of loops and turns that were held together by disulfide bridges (the chymotrypsin-binding region). Structural similarities between the GR1 protein and the Bowman-Birk inhibitor existed only in the trypsin-binding site of the Bowman-Birk inhibitor. The GR1 protein is the first member of the Proteaceae family to be characterised as a Bowman-Birk inhibitor. This thesis outlines the isolation and biochemical characterisation of the two proteins found within Grevillea robusta and also describes the steps involved and results obtained in determining the three-dimensional structure of the GR1 protein.
5
Kruger, Sarah Jane. "Characterisation of Proteins from Grevillea robusta and NMR Studies of the Serine Protease Inhibitor." Thesis, Griffith University, 2004. http://hdl.handle.net/10072/366534.
Full textAbstract:
Proteins that recognise the sugar surface structures on cells have an enormous potential to be used as tools in the characterisation of these structures. A group of proteins, called lectins, have been identified that can bind to carbohydrate complexes on the receptors of cells. The crude extract from Grevillea robusta seeds was found to contain lectin-like proteins that were different from most other lectins, as they would specifically target the receptors of white blood cells and not those found on red blood cells. Therefore, the lectin isolated from G.robusta could be used as a tool to identify the specific surface structures on white blood cells. The lectin was isolated using affinity chromatography where a complex (oligosaccharide) matrix was used. Agglutination, binding and sugar inhibition assays confirmed the isolated protein was a lectin. The lectin was found in low amounts (up to 5% of the total protein content) within the seeds of G.robusta. As a result of this low yield, the identification of the lectin by PAGE was difficult because the levels of protein were beyond the detection limit of the commercial staining reagents. The lectin was called the GR2 protein and was characterised as a monocot mannose binding lectin based on its sugar specificity for only mannose. A serine protease inhibitor was isolated from the seeds of G.robusta using two different chromatography methods, reverse phase HPLC (GR1.HPLC) and gel filtration chromatography (GR1.GF). Ion exchange chromatography was used to initially separate the proteins in the crude extract and the fraction containing the GR1 protein was further purified using reverse phase HPLC (GR1.HPLC). N-terminal sequencing results of the GR1.HPLC protein, showed evidence of proteolytic cleavage during the extraction process, which lead to the second purification method being established. Protease inhibitors were added to the buffers prior to being purified by gel filtration chromatography, which resulted in the GR1 protein being isolated from the crude extract without the presence of the contaminating protein. Mass spectroscopy identified the molecular weight of the GR1 protein to be 6669Da and the full amino acid sequence was derived by cDNA techniques. Sequence alignment studies of the GR1 protein showed significant similarities with the Bowman-Birk inhibitor. The positioning of the cysteine residues were conserved throughout the Bowman-Birk superfamily, however these residues were not conserved within the GR1 protein. Competitive inhibition assays on the GR1 protein revealed the protein could inhibit both trypsin and chymotrypsin at similar levels to that seen for the Bowman-Birk inhibitor. Therefore, the GR1 protein was characterised as a member of the Bowman-Birk superfamily of serine protease inhibitors. The three-dimensional structure of the GR1 protein was determined using two-dimensional NMR spectroscopy. Computer programs such as XEASY, DYANA and SYBYL® were used to tabulate the information taken from the 2D experiments, generate structures and minimise these structures respectively. The solution structure of the GR1 protein was found to contain a region of antiparallel β-sheet structure that corresponded to the trypsin binding site and the remainder of the protein consisted of loops and turns that were held together by disulfide bridges (the chymotrypsin-binding region). Structural similarities between the GR1 protein and the Bowman-Birk inhibitor existed only in the trypsin-binding site of the Bowman-Birk inhibitor. The GR1 protein is the first member of the Proteaceae family to be characterised as a Bowman-Birk inhibitor. This thesis outlines the isolation and biochemical characterisation of the two proteins found within Grevillea robusta and also describes the steps involved and results obtained in determining the three-dimensional structure of the GR1 protein.<br>Thesis (PhD Doctorate)<br>Doctor of Philosophy (PhD)<br>School of Science<br>Full Text
6
Tchanque, Kemtchou Valéry. "Magnetit-Nanokomposite als Funktionspartikeln für die Bioseparation." Doctoral thesis, Technische Universitaet Bergakademie Freiberg Universitaetsbibliothek "Georgius Agricola", 2014. http://nbn-resolving.de/urn:nbn:de:bsz:105-qucosa-156369.
Full textAbstract:
Die vorliegende Arbeit beschäftigt sich mit der Herstellung von funktionellen Magnetit-Nanokompositen durch Sprühtrocknung für die Anwendung in der Bioseparation. Dabei liegen die Schwerpunkte auf der Anwendung von Polyelektrolyten als Ionenaustauscher sowie auf der Nachhaltigkeit des Herstellungsprozesses.
Basierend auf einem existierenden Herstellungsprozess wurde die Aufgabenstellung konkretisiert. Es wurden Möglichkeiten zur nachhaltigen Prozessgestaltung der Synthese von kationischen bzw. anionischen magnetischen Funktionspartikeln zur Proteinabtrennung vorgestellt. Als magnetische Komponente wurde Magnetit verwendet. Aufgrund seines pseudo-amphiphilen Charakters und seiner besonderen Eigenschaften in Bezug auf die Stabilisierung von Magnetit-Kolloiden wurde Polyvinylbutyral (Mowital B 30T) als Matrixpolymer bei der Sprühtrocknung benutzt. Für die nachhaltige Prozessgestaltung wurden Isopropanol und Tetrahydrofuran als Dichlormethan-Ersatz bei der Sprühtrocknung verwendet.
Bei der Synthese kationischer Magnetic Beads wurden verzweigtes Polyethylenimin und lineares Poly(Allyamin) als Anionenaustauscher verwendet. Beide Polykationen sind schwache Polyelektrolyte mit Aminogruppen. Für die Verarbeitung der Polykationen als funktionelle Liganden in magnetischen Funktionspartikeln wurde zwei Herstellungsmethoden vorgestellt: eine Synthese ohne Oberflächenmodifizierung, wobei die mechanische und chemische Stabilität der Funktionspartikeln einzig von der chemischen Struktur der eingesetzten Materialien bzw. vom Matrixpolymer abhängt, und eine Synthese mit Oberflächenmodifizierung. Die Synthese mit Oberflächenmodifizierung ist gekennzeichnet durch die kovalente Bindung von Polyethylenimin bzw. Poly(Allyamin) an der Oberfläche der Funktionspartikeln (Polyvinylbutyral). Dafür wurde 1,1’-Carbonyldiimidazol als „zero length“-Crosslinker benutzt. Die nach beiden Methoden hergestellten Funktionspartikeln wurden charakterisiert, um ihre technische Eignung beurteilen zu können. Für die Charakterisierung der sorptiven Eigenschaften wurde unter anderem der Bowman-Birk Inhibitor (BBI) verwendet. Das Protein ist ein Sojaprodukt und für seine krebsvorbeugende Wirkung bekannt. Um die Selektivität der Abtrennung zu untersuchen, wurden BBI-Produkte mit unterschiedlichen Reinheitsgraden benutzt.
Durch die zwei vorgestellten Methoden konnten kationische magnetische Funktionspartikeln erfolgreich hergestellt werden. Alle Funktionspartikeln sind superparamagnetisch, und der Medianwert ihrer Partikelgrößenverteilung liegt im einstelligen Mikrometerbereich. Aufgrund eines höheren Polykationanteils ist die Bindungskapazität der Funktionspartikeln ohne Oberflächenmodifizierung um den Faktor 2,4 größer als die BBI-Bindungskapazität der Funktionspartikeln mit Oberflächenmodifizierung (Qmax=322 mg/g). Das Fehlen eine feste Anbindung des funktionellen Liganden an den Funktionspartikeln ohne Oberflächenmodifizierung verleiht jedoch diesen eine sehr schlechte chemische Stabilität in Lösungen. Es wurde auch gezeigt, dass oberflächenmodifizierte Funktionspartikeln mit ähnlichen Eigenschaften durch den Einsatz von Dichlormethan bzw. Tetrahydrofuran als Lösungsmittelersatz während der Sprühtrocknung hergestellt werden können. Durch den Einsatz von mit Poly(allylamin) oberflächenmodifizierten Funktionspartikeln konnte BBI von technischen Sojamolken unterschiedlicher Reinheitsgrade erfolgreich abgetrennt werden.
Anionische Magnetic Beads wurden mit Kationenaustauscherharz als funktionellem Ligand hergestellt. Dabei wurde Isopropanol als organisches Lösungsmittel während der Sprühtrocknung verwendet. Die Synthese wurde analog zur Synthese der kationischen Magnetic Beads ohne Oberflächenmodifizierung durchgeführt. Es wurde auch hier gezeigt, dass anionische magnetische Funktionspartikeln mit guten sorptiven Eigenschaften durch den Einsatz von Isopropanol als organisches Lösungsmittel hergestellt werden können. Die anionischen Funktionspartikeln besitzen im Vergleich zu Literaturwerten höhere Bindungskapazitäten (bis 280 mg/g; ermittelt mit Lysozym).
Im letzten Kapitel wird der kritische Prozessschritt des Lösungsmittelaustausches behandelt. Nach dem Lösungsmittelaustausch sollten die Magnetitnanopartikeln in der organischen Phase stabil sein. Dies ermöglicht sowohl eine homogene Verteilung der Nanopartikeln in der Matrix als auch deren bessere Verkapselung während der Sprühtrocknung. Es wurde festgestellt, dass sich eine vollständige Abtrennung von Dichlormethan durch die angewendete Destillationsmethode nicht erreichen lässt. Anhand von zwei Modellsystemen — Rizinolsäure- und Ölsäure-beschichteten Magnetitnanopartikeln — und Lösungsmittelgemischen wurde die Stabilität von sterisch stabilisierten Magnetitpartikeln in binären Lösungsmittelgemischen untersucht. Der Fokus bei dieser Untersuchung lag auf der Untersuchung der Stabilität der beschichteten Magnetitnanopartikeln in einer möglichst Dichlormethan- bzw. Isooktan-freien organischen Phase. Als zweites Lösungsmittel (als Lösungsmittelersatz betrachtet) wurden neben Tetrahydrofuran und Isopropanol technisch verbreitete Lösungsmittel wie Isooktan und 1-Butanol eingesetzt.
Die Untersuchungsergebnisse zeigen, dass die Anwendung der technischen Rizinolsäure bzw. Ölsäure einen zusätzlichen Einfluss auf die Stabilität der Magnetitpartikeln hat, da diese aus anderen Fettsäuren mit unterschiedlichen chemischen Strukturen bestehen. Die Diskrepanz zwischen der berechneten HANSEN-Distanzen und der Stabilität der Magnetitnanopartikeln mit reinen Fettsäuren lässt vermutet, dass die Zusammensetzung der Lösungsmittelgemische an der fest/flüssig-Grenzfläche anders ist als im freien Volumen. Ein Modell zur Beschreibung der Stabilität der Nanopartikeln, das auf einer Anreicherung des Ausgangslösungsmittels an der Grenzfläche basiert, wurde postuliert. Solange die Diffusion des zweiten Lösungsmittels in die Adsorptionsschicht nicht ausreichend genug ist, um die Löslichkeit der Fettsäureketten entscheidend zu reduzieren und somit einen Abfall der Abstoßungskräfte zwischen der Partikeln hervorzurufen, bleiben alle beschichteten Magnetitnanopartikeln stabil im Lösungsmittelgemisch. Dies ist der Fall für die mit der reinen Rizinolsäure beschichteten Magnetitnanopartikeln in allen verwendeten Lösungsmittelgemischen mit 0,5 Vol. % DCM in der kontinuierlichen Phase.
Durch die vorgestellten Herstellungsmethoden wurde gezeigt, dass magnetische Funktionspartikeln sowohl mit festen partikelförmigen Ionenaustauschern als auch mit flüssigen schwachen Polyelektrolyten erfolgreich synthetisiert werden können. Eine nachhaltige Prozessgestaltung durch die Reduzierung der Dichlormethanmenge im Sprühtrocknungsprozess ist auch möglich. Für eine erfolgreiche industrielle Anwendung der Funktionspartikeln müssen aber ihre chemischen sowie mechanischen Eigenschaften deutlich verbessert werden. Dies könnte z.B. durch die Verwendung eines anderen Matrixpolymers oder durch die Entfernung von nicht gebundenen Bestandteilen durch gezielte Waschung der Funktionspartikeln erfolgen. Die Bindungskapazität sowie die Selektivität der oberflächenmodifizierten Funktionspartikeln sollte ebenfalls verbessert werden. Dafür wurde einen Ansatz durch die Quaternisierung der Aminogruppen präsentiert.
Schließlich würde die Untersuchung der Stabilität der beschichteten Magnetitnanopartikeln in einphasigen reinen Lösungsmitteln nähere Erkenntnisse über das postulierte Modell der Anreicherung von Dichlormethan in der Adsorptionsschicht erbringen. Dabei könnte die Dichlormethanmenge durch mehrstufige Destillation bzw. Rektifikation beim Lösungsmittelaustausch entfernt werden. Eine vollständige Untersuchung dieses Effekts würde zusätzlich eine Antwort auf zahlreiche Fragestellungen der Kolloidchemie in Bezug auf das Stabilitätsverhalten von Pigmentdispersionen (Lacke) oder von beschichteten Nanopartikeln in Polymerlösungen erbringen.
7
PANZERI, DAVIDE. "A Bioprospecting Multidisciplinary Approach to Valorise Biodiversity: The Case of Bowman-Birk Protease Inhibitors in Vigna unguiculata (L.) Walp." Doctoral thesis, Università degli Studi di Milano-Bicocca, 2023. https://hdl.handle.net/10281/404605.
Full textAbstract:
La biodiversità naturale è un’importante risorsa per l’uomo sin da tempi antichi. Tuttavia, sta sperimentando un critico declino e molte specie sono a rischio estinzione. Il cambiamento climatico e l’attività umana sono i maggiori drivers di una conservazione e gestione del territorio non sostenibili. L’opportunità di ammortizzare gli effetti del cambiamento climatico è fornita da specie indigene, domesticate in contesti locali ma poco investigate.
In questo contesto, questa tesi mira a sviluppare strategie per valorizzare la biodiversità naturale, considerando diversi e integrati aspetti scientifici. Il primo obiettivo è quello di riscoprire un legume tradizionale africano, Vigna unguiculata (L.) Walp., e verificare la sua adattabilità a condizioni di stress tipiche del cambiamento climatico o pratiche agricole poco esigenti. La ricerca di composti bioattivi è un valore aggiunto al fine di dare coscienza della potenzialità della specie. Per questa ragione, i successivi obiettivi della tesi sono l’esplorazione della diversità genetica di composti bioattivi dei legumi, gli inibitori delle proteasi Bowman-Birk (BBIs), e la valutazione delle proprietà nutraceutiche.
Un design sperimentale multidisciplinare è stato applicato integrando diversi approcci per creare un flusso di lavoro coerente. Un esperimento di campo e analisi di produzione e metaboliti è stato organizzato per dimostrare l’adeguatezza di Vigna unguiculata come coltivazione per il cambiamento climatico. La diversità genetica di questa specie è stata esplorato con tecniche di biologia molecolare e analisi computazionali e filogenetiche. Le proprietà nutraceutiche sono state determinate grazie a procedure biochimiche e test su modelli, cellulari e in vivo, di cancro ed invecchiamento.
Dal punto di vista della coltivazione, Vigna unguiculata può essere considerata una specie poco esigente in termini di richiesta d’acqua e pratiche agronomiche. Ciò rende questo legume adatto a pratiche di agricoltura conservativa in paesi in via di sviluppo o in quei paesi colpiti fortemente dal cambiamento climatico. Questo legume si dimostra importante come risorsa di macronutrienti essenziali, e, per promuovere la sua diffusione a livello globale, abbiamo indagato anche la presenza di molecole con azione dirette per la salute umana. L’esplorazione genetica ha considerato quasi 200 accessioni, tovando13 diverse isoforme di BBI tra accessioni selvatiche e domesticate distribuite sul continente Africa e in altre parti del mondo. In aggiunta, abbiamo sviluppato una metodica estrattiva e purificative che ha permesso l’isolamento e caratterizzazione delle singole isoforme di BBI. La dimostrazione di attività correlate a BBI nei diversi modelli, rende questa famiglia di proteine un valore aggiunto per la salute umana. L’azione verso linee cellulari tumorali suggerisce possibili applicazioni terapeutiche anche in sinergia con farmaci d’elezione. Ciò apre opportunità per la futura ricerca in specie e generi affini e la valutazione di isoforme maggiormente efficaci anche in sistemi in vivo.
Concludendo, questo progetto dimostra che i) la bioprospezione per la ricerca di molecole bioattive in specie regionali è un importante passo per la loro salvaguardia, ii) conoscere evoluzione e diversificazione di piante di interesse è uno strumento per migliorare azioni bioprospettive e identificare migliori varianti di composti bioattivi, iii) analisi di efficacia funzionale in vitro e in vivo è un passaggio fondamentale per dedicare ricerca scientifica al miglioramento della biodiversità in contesti operativi. Quest’ultima è una fase importante per stimolare investitori, sia privati che pubblici, al fine di portare valore economico e sociale alla conservazione della biodiversità.<br>Natural biodiversity is an important source for humans since ancient times. However, biodiversity is experiencing a dramatic decline and many species are at extinction risk. Climate change and human activity are the main drivers of non-sustainable landscape conservation and management. The opportunity to dampen climate change effects is provided by indigenous species, domesticated in local contexts but are little investigated.
In this framework, this PhD thesis aims at developing strategies to valorise natural biodiversity, considering different integrative scientific aspects. The first objective of this thesis is the rediscovery of a traditional African legume, Vigna unguiculata (L.) Walp., and assess its adaptability to stressful conditions typically caused by climate change or undemanding agricultural practices. Moreover, the research for bioactive compounds is an added value to give consciousness of the species potential. For this purpose, exploration of genetic diversity of known legume bioactive compounds, the Bowman-Birk protease inhibitors (BBIs) and appraisal of their nutraceutical properties are the second objectives of the project.
A multidisciplinary experimental overview has been applied by integrating different approaches to create a coherent workflow. The demonstration of Vigna unguiculata L. as suitable species for climate change was carried out with a field experiment and subsequent laboratory analyses to evaluate production parameters and metabolic features. The genetic diversity of this species was explored through molecular biology techniques and in silico computational and phylogenetic analyses. The nutraceutical features were established by biochemical procedures and cellular biology by testing compounds on different ageing and cancer models.
From the point of view of cultivation needs, it is possible to consider V. unguiculata (L.) Walp. as undemanding in terms of water demand and agronomic practices. This makes this legume suitable for conservation agriculture practices in developing countries and where climate change is having a dramatic impact on indigenous crop. This legume is also an important resource of essential macronutrients and to enhance this species and promote its cultivation globally, we also wanted to focus on the presence of bioactive molecules with direct action on humans. The genetic exploration considered almost 200 accessions and found 13 isoforms of BBI were identified in different wild and cultivated accessions, distributed in the African continent and in other areas of the world. Furthermore, we managed to develop an extraction and purification procedure to isolate single isoforms and characterise them. Our data suggest that V. unguiculata BBIs possess a great natural genetic and biochemical diversity. Moreover, the demonstration of BBI-related bioactivities on different models makes them very promising as a high-value natural compound for human wellbeing. The direct action on different tumour cell lines suggests a possible therapeutic application also in synergy with some drugs (i.e. Cetuximab). This opens opportunities for future research on similar related species and genera, and on the analyses to evaluate the most effective isoforms also in in vivo systems.
In conclusion, this PhD project demonstrates that i) bioprospection of local species directed to the search for bioactive molecules represents an important lever for safeguarding; ii) the knowledge of evolution and diversification of the plants of interest is a tool to improve bioprospecting actions and identify molecular variants of bioactive compounds; iii) analyses of functional efficacy of bioactive compounds in in vitro and in vivo systems is a fundamental step to dedicate scientific research to the enhancement of biodiversity in an operational context. This is an essential phase to stimulate private investors and businesses to bring economic and social value and biodiversity conservation.
8
Nievo, Marco. "Peptidic inhibitors of serine proteases : variations on a cyclic template based on the reactive site loop of Bowman Birk inhibitors." Thesis, Imperial College London, 2003. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.407519.
Full text
9
Dantzger, Miriam 1981. "Inibidor de proteinase do tipo Bowman-Birk isolado de sementes de Clitoria fairchildiana (Fabaceae) : caracterização e atividade biológica sobre Anagasta kuehniella e Corcyra cephalonica." [s.n.], 2014. http://repositorio.unicamp.br/jspui/handle/REPOSIP/314532.
Full textAbstract:
Orientador: Maria Lígia Rodrigues Macedo<br>Tese (doutorado) - Universidade Estadual de Campinas, Instituto de Biologia<br>Made available in DSpace on 2018-08-26T06:33:25Z (GMT). No. of bitstreams: 1
Dantzger_Miriam_D.pdf: 2351280 bytes, checksum: b2da4015dedd7611bbce146ad9143d6f (MD5)
Previous issue date: 2014<br>Resumo: Os inibidores de proteinases extraídos de plantas têm se mostrado promissores como um método alternativo no combate aos insetos-pragas. Neste estudo, um inibidor de peptidase foi isolado de sementes de Clitoria fairchildiana (Papilionoideae), denominado CFPI, caracterizado funcional e estruturalmente e sua atividade inseticida foi avaliada. CFPI foi purificado por exclusão molecular, seguido por coluna de interação hidrofóbica e apresentou um pico majoritário com atividade inibitória após ter sido submetido à filtração com alta resolução. Estudos cinéticos realizados com CFPI purificado mostraram uma atividade inibitória do tipo competitiva contra tripsina e quimotripsina bovinas, com uma estequiometria de inibição de 1:1 para ambas as enzimas. A constante de inibição de CFPI contra tripsina e quimotripsina bovinas foram 3,3 x 10-10 e 1,5 x 10-10 M, respectivamente, revelando uma forte capacidade de ligação. Eletroforese em SDS-Page mostrou que CFPI possui uma única cadeia polipeptídica, com uma massa molecular aparente de 15 kDa, sob condições não redutoras. Entretanto, o inibidor apresentou uma massa acurada de 7973 Daltons determinada por MALDI-TOF, sugerindo que CFPI forme dímeros em solução. Essa característica, aliada à estequiometria de inibição para tripsina e quimotripsina, à constante de inibição (Ki) para ambas as enzimas e ao sequenciamento e alinhamento N-terminal, permitiram classificar CFPI como membro da família Bowman-Birk de inibidores. O inibidor manteve-se estável ao aquecimento progressivo por 30 min a cada temperatura, variando de 37 até 100 ?C e a análise de dicroísmo não mostrou mudanças no espectro a 207 nm após aquecimento à 90 ?C e subsequente resfriamento. Além disso, CFPI mostrou atividade sobre uma ampla faixa de pH (2-10). Em contraste, a redução de CFPI com DTT resultou em perda de atividade inibitória contra tripsina e quimotripsina. CFPI exibiu atividade inibitória considerável contra enzimas tripsinas de Anagasta kuehniella (76%), Diatraea saccharalis (59%) e Heliothis virescens (49%). Suas propriedades inseticidas foram confirmadas a partir do impacto negativo causado no crescimento de A. kuehniella e C. cephalonica. O inibidor exerceu efeito antinutricional sobre A. kuehniella tanto na geração F0 como em F1<br>Abstract: Proteinase inhibitors isolated from plants have shown a promising alternative method against insect pests. In this study, a proteinase inhibitor was isolated from Clitoria fairchildiana seeds (CFPI). CFPI was functional and structurally characterized and its insecticidal activity was evaluated. CFPI was purified by molecular exclusion, following by hydrophobic interaction column and showed a majoritarian peak with inhibitory activity after high resolution filtration gel column. Kinetic studies of the purified inhibitor showed a competitive¿type inhibitory activity against bovine trypsin and chymotrypsin, with an inhibition stoichiometry of 1:1 for both enzymes. The inhibition constants against trypsin and chymotrypsin were 3.3 ×10?10 and 1.5 × 10?10 M, respectively, displaying a tight binding property. SDS¿PAGE showed that CFPI has a single polypeptide chain with an apparent molecular mass of 15 kDa under non¿reducing conditions. However, MALDI¿TOF analysis demonstrated a molecular mass of 7.973 Da, suggesting that CFPI forms dimers in solution. This feature, combined with the stoichiometry of inhibition for trypsin and chymotrypsin, the inhibition constant (Ki) for both enzymes and the N-terminal sequencing, allowed classifying CFPI as a member of Bowman-Birk family inhibitors. CFPI remained stable to progressive heating for 30 min to each temperature range of 37 up to 100 °C and CD analysis exhibited no changes in spectra at 207 nm after heating at 90 °C and subsequent cooling. Moreover, CFPI was active over a wide pH range (2¿10). In contrast, reduction with DTT resulted in a loss of inhibitory activity against trypsin and chymotrypsin. CFPI also exhibited remarkable inhibitory activity against larval midgut trypsin enzymes from Anagasta kuehniella (76%), Diatraea saccharalis (59%) and Heliothis virescens (49%). Its insecticidal properties were further analysed by bioassays and confirmed by negative impact on growth of A. kuehniella and C. cephalonica. The inhibitor exhibited antinutritional effect on A. kuehniella in the F0 and F1 generations<br>Doutorado<br>Bioquimica<br>Doutora em Biologia Funcional e Molecular
10
yu-Ting, Tasi, and 蔡育廷. "The Inhibition Study of the Rice Coleoptile Bowman - Birk Trypsin Inhibitor." Thesis, 2005. http://ndltd.ncl.edu.tw/handle/97114217734752156078.
Full textAbstract:
碩士<br>國立成功大學<br>化學系碩博士班<br>93<br>A 16 kDa protease inhibitor had been purified from rice coleoptiles grown in hypoxia condition. This protease inhibitor showed a competitive inhibitor toward trypsin. In order to study the optimum inhibitory ability of this protease, we had measured its activity against trypsin under various pHs and in the presence of Mg2+. It was found that under weak basic condition, it showed better activity to inhibit trypsin. To further study the effect of the presence of Mg2+, various concentration of Mg2+ were added. It was found that at pH7.8 and with the presence of 0 M, 0.5 M, 1.0 M, 1.5 M, and 2.0 M of Mg2+, the respective Ki values were 4.84 x 10-10 M, 4.56 x 10-10 M, 4.39 x 10-10 M, 3.07 x 10-10 M, and 2.45 x 10-10 M, showing that the inhibitory activity in the presence of 2.0 M Mg2+ was about twofold of that without the presence of Mg2+. By contrast, same measurements for soybean protease inhibition activity, it was found that with the increase of the concentration of Mg2+ the inhibition activity decreased with the respective Ki values were 4.21 x 10-11 M, 6.24 x 10-11 M, 8.46 x 10-11 M, 9.34 x 10-11 M, and 1.18 x 10-10 M. It was found that the secondary structures were change with the presence of 2 M of Mg2+, whereas the tertiary structure was unchanged. The fluorescence study showed that the tryptophan fluorescence intensity increased indicating that there was a micro-environmental change around the tryptophan residues. ANS fluorescence also showed there was an increase for hydrophobic area in the presence of Mg2+. The MIANS fluorescence study showed that rice protease inhibitor resulted in the increase of intensity, however, with the presence of Mg2+, the intensity decreased.
Book chapters on the topic "Bowman-Birk inhibitor"
1
Kennedy, Ann R. "The Health Benefits of the Bowman-Birk Inhibitor." In Antitumor Potential and other Emerging Medicinal Properties of Natural Compounds, 183–86. Dordrecht: Springer Netherlands, 2013. http://dx.doi.org/10.1007/978-94-007-6214-5_11.
Full text
2
Flecker, Peter. "Analysis of Structure-Activity Relationships of the Bowman-Birk Inhibitor of Serine Proteinases." In Protease Inhibitors as Cancer Chemopreventive Agents, 161–76. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2882-1_9.
Full text
3
Bowman, Donald E. "Discovery and Background of the Bowman-Birk Protease Inhibitors." In Protease Inhibitors as Cancer Chemopreventive Agents, 93–96. Boston, MA: Springer US, 1993. http://dx.doi.org/10.1007/978-1-4615-2882-1_4.
Full text
4
Clemente, Alfonso, Donald MacKenzie, David Jeenes, Jenny Gee, Ian Johnson, and Claire Domoney. "Anticarcinogenic Properties of Plant Protease Inhibitors from the Bowman-Birk Class." In Plant Biotechnology 2002 and Beyond, 429–31. Dordrecht: Springer Netherlands, 2003. http://dx.doi.org/10.1007/978-94-017-2679-5_89.
Full text
5
"Bowman-Birk Inhibitor." In Encyclopedia of Cancer, 464. Berlin, Heidelberg: Springer Berlin Heidelberg, 2011. http://dx.doi.org/10.1007/978-3-642-16483-5_695.
Full text
6
Safavi, Farinaz, and Abdolmohamad Rostami. "Bowman-Birk Protease Inhibitor as a Potential Oral Therapy for Multiple Sclerosis." In Soybean - Bio-Active Compounds. InTech, 2013. http://dx.doi.org/10.5772/54066.
Full text
7
Kennedy, Ann R. "The Status of Human Trials Utilizing Bowman–Birk Inhibitor Concentrate from Soybeans." In SOY in Health and Disease Prevention, 207–23. CRC Press, 2005. http://dx.doi.org/10.1201/9781420026566-12.
Full text
8
Kennedy, Ann. "The Status of Human Trials Utilizing Bowman–Birk Inhibitor Concentrate from Soybeans." In Nutrition and Disease Prevention, 207–23. CRC Press, 2005. http://dx.doi.org/10.1201/9781420026566.ch12.
Full text
9
"The Con A Conjugate of Bowman-Birk Soybean Trypsin Inhibitor is an Anticarcinogen." In Proceedings of IUB Symposium No. 144, The Seventh International Lectin Meeting Bruxelles, Belgium, August 18–23, 1985, 409–16. De Gruyter, 1986. http://dx.doi.org/10.1515/9783112315958-048.
Full text
10
"Bowman‐Birk Inhibitors." In Encyclopedia of Genetics, Genomics, Proteomics and Informatics, 230. Dordrecht: Springer Netherlands, 2008. http://dx.doi.org/10.1007/978-1-4020-6754-9_1995.
Full textConference papers on the topic "Bowman-Birk inhibitor"
1
Liu, Keshun, and Mike Woolman. "Developing an optimized method for measuring chymotrypsin inhibitor activity in protein products." In 2022 AOCS Annual Meeting & Expo. American Oil Chemists' Society (AOCS), 2022. http://dx.doi.org/10.21748/yucc6741.
Full textAbstract:
Protease inhibitors of protein nature, such as trypsin inhibitors and chymotrypsin inhibitors, are rich in seeds of legume crops. Soybeans contain Kunitz inhibitor and Bowman-Birk inhibitor. The former mainly inhibits trypsin, while the latter inhibits both trypsin and chymotrypsin. Other legumes contain similar types. Historically, trypsin inhibitor activity in legume products has been of primary interest for measurement due to its antinutritional implication. However, Bowman-Birk inhibitor has been shown therapeutic. It is also more resistant to heat than Kunitz inhibitor. As increasing volumes of plant proteins are being used for food or feed in recent years, there is a growing interest in monitoring chymotrypsin inhibitor activity (CIA) in these products as well. Yet, reported methods for CIA assay vary greatly, with no standard method being available. Three years ago, at our USDA lab, we developed an improved method for measuring trypsin inhibitor activity, which was later adopted as AOCS Official Method, Ba 12a-2020. This presentation reports our new effort in developing a method for measuring CIA, using N-benzoyl-L-tyrosine p-nitroanilide (BTpNA) as a substrate. Unlike the substrate for measuring trypsin inhibitor activity, BTpNA is not water soluble, an organic solvent that is miscible with water must be present. Therefore, the assay system for measuring CIA was much more complicated than that for measuring trypsin inhibitor activity. This made the method development more difficult than originally thought. After investigating effects of many assay parameters, such as organic solvent, the sequence of adding reagents, % chymotrypsin inhibition, etc., an optimized method for CIA measurement was finally developed. It featured dimethylformamide as the organic solvent, the enzyme-last sequence, 5 mL total assay volume, and calculation of the inhibitor activity based on % chymotrypsin inhibition. The proposed method was reliable and robust and could be standardized for measuring CIA in various protein products.
2
Meyskens, Frank L., Thomas Taylor, William Armstrong, Lorene Kong, Mai Gu, Rachel Gonzalez, Michael Villa, et al. "Abstract CN02-05: Phase IIb randomized clinical chemoprevention trial of a soybean-derived compound (Bowman-Birk inhibitor concentrate) for oral leukoplakia." In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Nov 7-10, 2010; Philadelphia, PA. American Association for Cancer Research, 2010. http://dx.doi.org/10.1158/1940-6207.prev-10-cn02-05.
Full text
3
Taylor, Thomas H., Ann R. Kennedy, Marjorie Perloff, and Frank L. Meyskens. "Abstract B82: Two factors contribute to negative results of a phase-IIB chemoprevention trial of Bowman-Birk inhibitor concentrate on oral leukoplakia." In Abstracts: AACR International Conference on Frontiers in Cancer Prevention Research‐‐ Oct 22-25, 2011; Boston, MA. American Association for Cancer Research, 2011. http://dx.doi.org/10.1158/1940-6207.prev-11-b82.
Full text